Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
Authors
Keywords
-
Journal
Lancet Digital Health
Volume 5, Issue 2, Pages e71-e82
Publisher
Elsevier BV
Online
2022-12-08
DOI
10.1016/s2589-7500(22)00210-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
- (2022) Nanda Horeweg et al. Nature Communications
- Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application
- (2022) A. Echle et al. ESMO Open
- DeepSMILE: Contrastive self-supervised pre-training benefits MSI and HRD classification directly from H&E whole-slide images in colorectal and breast cancer
- (2022) Yoni Schirris et al. MEDICAL IMAGE ANALYSIS
- Data-efficient and weakly supervised computational pathology on whole-slide images
- (2021) Ming Y. Lu et al. Nature Biomedical Engineering
- Genetic mutation and biological pathway prediction based on whole slide images in breast carcinoma using deep learning
- (2021) Hui Qu et al. npj Precision Oncology
- Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features
- (2021) Eun Young Kang et al. Journal of Pathology Clinical Research
- Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
- (2020) Korsuk Sirinukunwattana et al. GUT
- Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
- (2020) Alicia León-Castillo et al. JOURNAL OF CLINICAL ONCOLOGY
- PROGNOSTIC INTEGRATED IMAGE-BASED IMMUNE AND MOLECULAR PROFILING IN EARLY-STAGE ENDOMETRIAL CANCER
- (2020) Nanda Horeweg et al. Cancer Immunology Research
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
- (2020) Nicole Concin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study
- (2020) Rikiya Yamashita et al. LANCET ONCOLOGY
- Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains
- (2020) Nikhil Naik et al. Nature Communications
- Hover-Net: Simultaneous segmentation and classification of nuclei in multi-tissue histology images
- (2019) Simon Graham et al. MEDICAL IMAGE ANALYSIS
- Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
- (2018) Stephanie M de Boer et al. LANCET ONCOLOGY
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
- (2016) Ellen Stelloo et al. CLINICAL CANCER RESEARCH
- ImageNet Large Scale Visual Recognition Challenge
- (2015) Olga Russakovsky et al. INTERNATIONAL JOURNAL OF COMPUTER VISION
- Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
- (2015) Ellen Stelloo et al. MODERN PATHOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
- (2010) RA Nout et al. LANCET
- Multicenter cohort study on treatment results and risk factors in stage II endometrial carcinoma
- (2008) J.J. JOBSEN et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started